Travis Lee Anderberg, PHARM. D Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 209 N Broadway Ave, Miller, SD 57362 Phone: 605-853-3647 Fax: 605-853-3744 |
Lynn Marie Johnson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 904 E Donlin St, Miller, SD 57362 Phone: 605-870-0714 Fax: 605-852-2305 |
Mr. Trent Steven Merkwan, RPH Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 209 N Broadway Ave, Miller, SD 57362 Phone: 605-853-3647 Fax: 605-853-3744 |
News Archive
Cell Therapeutics, Inc. today announced that it has filed its Annual Report on Form 10-K for the year ended December 31, 2009. This filing is available for review on CTI's website at www.CellTherapeutics.com, or on the Securities and Exchange Commission's website at www.sec.gov.
In recent years, a number of scientific breakthroughs have led to the development of drugs that unleash the power of the immune system to recognize and attack cancer. Studies presented today at the 56th Annual Meeting of the American Society of Hematology highlight the enormous potential these novel treatments have for patients with a variety of hematologic disorders.
TearScience, Inc., a privately-held medical device company, today announced that it has received U.S. Food and Drug Administration (FDA) clearance for its next generation product of its LipiFlow Thermal Pulsation System, a medical device that treats evaporative dry eye by liquefying and evacuating obstructions in meibomian glands located in the eyelids.
Ford Motor Company continues to support the fight against breast cancer with several new initiatives. Ford announced a new partnership with music icon Patti LaBelle, a summer contest that will have people seeking to "Go the Extra Mile," and a new 2004 breast cancer awareness bandana designed by Lilly Pulitzer.
The research suggests that GPs are still managing individual risk factors such as blood pressure and cholesterol in isolation of one another, and are not adopting recommendations to treat a patient's overall or absolute risk. Absolute risk management is based on the principle that the major risk factors for cardiovascular disease act together. By taking this approach treatment can be targeted to those most likely to benefit.
› Verified 5 days ago